209 related articles for article (PubMed ID: 25036586)
1. Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review.
Ghio L; Cervetti A; Respino M; Belvederi Murri M; Amore M
J Psychiatr Pract; 2014 Jul; 20(4):294-300. PubMed ID: 25036586
[TBL] [Abstract][Full Text] [Related]
2. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
[TBL] [Abstract][Full Text] [Related]
3. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
McDaniel CH; Miotto KA
J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
[TBL] [Abstract][Full Text] [Related]
4. Pentobarbital for severe gamma-butyrolactone withdrawal.
Sivilotti ML; Burns MJ; Aaron CK; Greenberg MJ
Ann Emerg Med; 2001 Dec; 38(6):660-5. PubMed ID: 11719746
[TBL] [Abstract][Full Text] [Related]
5. Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons.
Goodwin AK; Griffiths RR; Brown PR; Froestl W; Jakobs C; Gibson KM; Weerts EM
Psychopharmacology (Berl); 2006 Nov; 189(1):71-82. PubMed ID: 17047936
[TBL] [Abstract][Full Text] [Related]
6. ["Liquid ecstasy": gamma-butyrolactone withdrawal delirium with rhabdomyolysis and dialysis dependent renal failure].
Supady A; Schwab T; Busch HJ
Dtsch Med Wochenschr; 2009 Apr; 134(18):935-7. PubMed ID: 19384813
[TBL] [Abstract][Full Text] [Related]
7. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
[TBL] [Abstract][Full Text] [Related]
8. Gamma-butyrolactone (GBL) dependence and withdrawal.
Bell J; Collins R
Addiction; 2011 Feb; 106(2):442-7. PubMed ID: 20925687
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
[TBL] [Abstract][Full Text] [Related]
10. Inpatient management of GHB/GBL withdrawal.
Delic M
Psychiatr Danub; 2019 Sep; 31(Suppl 3):354-356. PubMed ID: 31488752
[TBL] [Abstract][Full Text] [Related]
11. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA
Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
[TBL] [Abstract][Full Text] [Related]
12. A case of γ-butyrolactone associated with severe withdrawal delirium and acute renal failure.
Bhattacharya IS; Watson F; Bruce M
Eur Addict Res; 2011; 17(4):169-71. PubMed ID: 21454980
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
Wojtowicz JM; Yarema MC; Wax PM
CJEM; 2008 Jan; 10(1):69-74. PubMed ID: 18226321
[TBL] [Abstract][Full Text] [Related]
14. [Acute gamma-butyrolactone poisoning with withdrawal syndrome].
Chwaluk P; Rejmak G
Przegl Lek; 2011; 68(8):537-8. PubMed ID: 22010460
[TBL] [Abstract][Full Text] [Related]
15. Gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4BD), and gamma-butyrolactone (GBL) intoxication: A state-of-the-art review.
Dufayet L; Bargel S; Bonnet A; Boukerma AK; Chevallier C; Evrard M; Guillotin S; Loeuillet E; Paradis C; Pouget AM; Reynoard J; Vaucel JA
Regul Toxicol Pharmacol; 2023 Aug; 142():105435. PubMed ID: 37343712
[TBL] [Abstract][Full Text] [Related]
16. A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol.
Schneir AB; Ly BT; Clark RF
J Emerg Med; 2001 Jul; 21(1):31-3. PubMed ID: 11399385
[TBL] [Abstract][Full Text] [Related]
17. Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
Palmer RB
Toxicol Rev; 2004; 23(1):21-31. PubMed ID: 15298490
[TBL] [Abstract][Full Text] [Related]
18. Gamma-butyrolactone (GBL) disruption of passive avoidance learning in the day-old chick appears to be due to its effect on GABAB not gamma-hydroxybutyric [corrected] acid (GHB) receptors.
Sherry JM; Hazi A; Hale MW; Milsome SL; Crowe SF
Behav Brain Res; 2009 Feb; 197(2):347-55. PubMed ID: 18948143
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): implications for psychiatry services in the general hospital.
Choudhuri D; Cross S; Dargan PI; Wood DM; Ranjith G
Int J Psychiatry Clin Pract; 2013 Jun; 17(2):154-6. PubMed ID: 23485126
[TBL] [Abstract][Full Text] [Related]
20. Unusual presentation of a patient with GBL withdrawal: a case report.
Kashyap GL; Patel AG
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S32-4. PubMed ID: 21894099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
